title: Convergence of redox-sensitive and mitogen-activated protein kinase signaling pathways in tumor necrosis factor-alpha-mediated monocyte chemoattractant protein-1 induction in vascular smooth muscle cells.
abstract: Monocyte chemoattractant protein-1 (MCP-1) is an important component of the inflammatory response of the vessel wall and has been shown to be regulated by cytokines, such as tumor necrosis factor-alpha (TNF-alpha). However, the precise signaling pathways leading to MCP-1 induction have not been fully elucidated in vascular smooth muscle cells (VSMCs). Cytokine signal transduction involves protein kinases as well as reactive oxygen species (ROS). The relation between these 2 factors is not clear. In this study, we show that TNF-alpha induces a parallel phosphorylation of extracellular signal-regulated kinase 1/2 (ERK1/2) and p38 mitogen-activated protein kinase (p38MAPK) and increases MCP-1 mRNA expression in cultured VSMCs. Inhibition of ERK1/2 but not p38MAPK caused a partial attenuation of MCP-1 induction (43+/-10% inhibition). Incubation of VSMCs with multiple antioxidants (diphenylene iodonium, liposomal superoxide dismutase, catalase, N-acetylcysteine, dimethylthiourea, and pyrrolidine dithiocarbamate) had no effect on TNF-alpha-mediated MCP-1 upregulation. However, simultaneous blockade of the ERK1/2 and ROS pathways by using PD098059 combined with diphenylene iodonium or N-acetylcysteine potently enhanced the ability of MAPK kinase inhibitors to abrogate MCP-1 mRNA expression (100+/-2% inhibition). Thus, parallel ROS-dependent and ERK1/2-dependent pathways converge to regulate TNF-alpha-induced MCP-1 gene expression in VSMCs. These data unmask a complex but organized integration of ROS and protein kinases that mediates cytokine-induced vascular inflammatory gene expression.
authors.affiliation: Division of Cardiology, Emory University School of Medicine, Atlanta, GA 30322, USA.
authors.forename: G W
authors.initials: GW
authors.lastname: De Keulenaer
authors.forename: M
authors.initials: M
authors.lastname: Ushio-Fukai
authors.forename: Q
authors.initials: Q
authors.lastname: Yin
authors.forename: A B
authors.initials: AB
authors.lastname: Chung
authors.forename: P R
authors.initials: PR
authors.lastname: Lyons
authors.forename: N
authors.initials: N
authors.lastname: Ishizaka
authors.forename: K
authors.initials: K
authors.lastname: Rengarajan
authors.forename: W R
authors.initials: WR
authors.lastname: Taylor
authors.forename: R W
authors.initials: RW
authors.lastname: Alexander
authors.forename: K K
authors.initials: KK
authors.lastname: Griendling
mesh_terms: D000818:Animals; D002478:Cells, Cultured; D018932:Chemokine CCL2 / Q000378:metabolism*; D020928:Mitogen-Activated Protein Kinases / Q000502:physiology*; D009131:Muscle, Smooth, Vascular / Q000166:cytology / Q000187:drug effects / Q000378:metabolism*; D010084:Oxidation-Reduction; D051381:Rats; D017382:Reactive Oxygen Species / Q000378:metabolism; D015398:Signal Transduction / Q000502:physiology*; D014409:Tumor Necrosis Factor-alpha / Q000494:pharmacology / Q000502:physiology*; D015854:Up-Regulation
chemical_list: D018932:Chemokine CCL2; D017382:Reactive Oxygen Species; D014409:Tumor Necrosis Factor-alpha; D020928:Mitogen-Activated Protein Kinases